Pfizer
Trade Pfizer 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About PFE
Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases.
PFE Key Statistics
Stock Snapshot
As of today, Pfizer(PFE) shares are valued at $26.83. The company's market cap stands at 152.33B, with a P/E ratio of 20.30 and a dividend yield of 6.3%.
During the trading session on 2026-04-22, Pfizer(PFE) shares reached a daily high of $27.43 and a low of $26.74. At a current price of $26.83, the stock is +0.3% higher than the low and still -2.2% under the high.
Trading volume for Pfizer(PFE) stock has reached 34.66M, versus its average volume of 29.39M.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $21.97.
Over the past 52 weeks, Pfizer(PFE) stock has traded between a high of $28.75 and a low of $21.97.
PFE News
Key Points AbbVie has managed its patent-cliff concerns better. Pfizer has a higher-yielding dividend, but it may not be safe. AbbVie has the better path to...
Tuesday’s total option volume of 67.7 million contracts resulted in net open interest growth of 6.90 million calls and 7.56 million puts. NVIDIA (NVDA), Apple (...
Pfizer (NYSE:PFE) plans to unveil major oncology pipeline updates at the ASCO 2026 Annual Meeting. The company will present new clinical data across its cancer...
Analyst ratings
52%
of 29 ratingsMore PFE News
Key Points Novo Nordisk and Eli Lilly are largely responsible for creating today's weight-loss drug market. The two companies, however, can’t fend off creativ...
Pfizer and Astellas received FDA Priority Review for PADCEV plus Keytruda as a perioperative treatment for muscle invasive bladder cancer. The application cove...
Astellas Pharma (ALPMY) and Pfizer (PFE) announced that the U.S. Food and Drug Administration accepted for Priority Review a supplemental Biologics License Appl...
Key Points Pfizer is facing patent cliffs on multiple drugs in the next few years. The company has been making big acquisitions to strengthen its growth prosp...
Pfizer ( (PFE) ) has been popular among investors this week. Here is a recap of the key news on this stock. Unlock hedge fund-level data and powerful investing...
If you are wondering whether Pfizer's current share price lines up with its fundamentals, this breakdown will help you focus on what the numbers actually say ab...
Pfizer Inc (PFE) announced an update on their ongoing clinical study. Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.